ASHG 2026 has ended. This guide stays up as the record of who was there. Next: ASHG 2027, Oct 26–30, 2027 in Nashville

Quest Diagnostics at ASHG 2026

Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website

Quest Diagnostics brings 5 presentations to ASHG 2026 in Montréal. Its program centres on rare disease testing, clinical variant classification, and repeat expansion analysis at this meeting. Its presentations cover population frequency thresholds for reclassifying variants and PacBio long-read sequencing to detect repeat expansions.

OrganizationASHG 2026 Attendance
Quest Diagnostics
Madison, New Jersey
1 Senior Staff Genomic Variant Scientist · 1 Genomic Variant Scientist III · 1 Sr Manager, Variant Science · 1 Senior Director, Genetics · 1 other presenter
Public company~60,000 people
Clinical laboratory and diagnostic information provider selling genetic tests, advanced diagnostics, and lab services to clinicians, health systems, pharma, biotech, and CROs.
Quest Diagnostics is letting Apple Health app users order tailored lab test panels directly, expanding its consumer lab-ordering channel.
›
Quest Diagnostics is letting Apple Health app users order tailored lab test panels directly, expanding its consumer lab-ordering channel.
2026-09 · source
Quest partnered with Humanity to launch a biological-age analysis report on questhealth.com, its first US offering of the kind.
2026-08 · source
Quest will offer an AD-Detect test based on the FDA-cleared Roche pTau217 assay, adding a new Alzheimer's diagnostic to its portfolio.
2026-08 · source
Source: company newsroom
Q2 2026 revenue $3.04B, up 10.2%
›
FY2026 revenue guidance raised to $11.95B-$12.05B, reflecting strong organic growth momentum. · 2026-07-23
“"Second quarter revenues of $3.04 billion, up 10.2% from 2025, with 10.0% organic revenue growth"; "Full year 2026 revenues now expected to be between $11.95 billion and $12.05 billion"”
Source: results release
Currently hiring: 2,166 open roles
›
Source: careers page
Poster
Wed Oct 21
2:30 pm
★ Reviewers’ Choice
Calibration of population allele frequency evidence for clinical variant classification using a variant-based disease allele frequency threshold determination method
Clinical geneticsVariant interpretationGenetic testingLaboratory genetics and genomics
Poster
Wed Oct 21
2:30 pm
Variant-based thresholds for applying population frequency evidence enable increased variant reclassification rates towards benign
Genetic testingVariant interpretationLaboratory genetics and genomicsClinical genetics
Poster
Wed Oct 21
2:30 pm
Poster
Fri Oct 23
2:30 pm
Co-occurrence of CLCN1 variants with myotonic dystrophy repeat expansions (DM1/DM2)
ChannelopathiesLaboratory genetics and genomicsMuscular abnormalitiesVariant interpretation
Poster
Fri Oct 23
2:30 pm
Detection of Repeat Expansions via PacBio Long-Read Sequencing in Patients Tested for Repeat Expansion Disorders
AtaxiaTriplet and other repeatsLong-read sequencingDiagnostics

Explore the full ASHG 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Montréal. Leave your work email and we’ll be in touch.

Privacy

Download the full ASHG 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Quest Diagnostics

Tell us what you sell and we’ll find the people at Quest Diagnostics most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction